From bench to bedside: the transformative power of AMH and inhibin B in reproductive health of women
10.3760/cma.j.cn101441-20241112-00414
- VernacularTitle:从实验室到临床：AMH 和抑制素 B 在女性生殖健康的变革力量
- Author:
Huiyu XU
1
;
Rong LI
1
Author Information
1. 女性生育力促进全国重点实验室 北京大学第三医院妇产科生殖医学中心，北京 100191
- Publication Type:Journal Article
- Keywords:
Anti-Müllerian hormone;
Inhibin B;
Ovarian reserve;
Reproductive health;
Biomarkers;
AI-driven diagnostic tool;
Personalized medicine
- From:
Chinese Journal of Reproduction and Contraception
2025;45(1):5-13
- CountryChina
- Language:Chinese
-
Abstract:
Anti-Müllerian hormone (AMH), known for its stable secretion patterns, has become a reliable indicator for evaluating ovarian reserve. Concurrently, inhibin B peaks around the seventh day of the menstrual cycle during the mid-follicular phase and provides unique insights into real-time ovarian function through its regulatory interactions with follicle-stimulating hormone. This article delves deeply into the crucial roles of AMH and inhibin B in assessing ovarian reserve and overall reproductive health. The article also discusses the importance of integrating AMH and inhibin B with other clinical indicators into artificial intelligence tools. This integration significantly enhances diagnostic precision, optimizes personalized treatment strategies, and advances the accuracy and convenience of ovarian function assessments. Furthermore, the article forecasts the future clinical applications of these biomarkers, emphasizing their central role in driving innovation and data-driven applications in reproductive health management.
